Triglycerides to High-Density Lipoprotein Cholesterol Ratio Predicts Chronic Renal Disease in Patients without

Vaia D Raikou1, Despina Kyriaki2, Sotiris Gavriil3

  • 1Department of Nephrology, Doctors' Hospital, 26 Kefallinias, Athens 11257, Greece.

Insights

The triglycerides to high-density lipoprotein cholesterol (TG/HDL-C) ratio may predict chronic kidney disease (CKD) progression in non-diabetic individuals. A higher TG/HDL-C ratio is linked to reduced kidney function and increased albuminuria, suggesting its role in arterial stiffening.

Area of Science:

  • Cardiovascular Health
  • Nephrology
  • Metabolic Syndrome

Background:

  • The triglycerides to high-density lipoprotein cholesterol (TG/HDL-C) ratio is a recognized marker for cardiovascular risk.
  • Its potential role in predicting atherosclerosis in chronic kidney disease (CKD) warrants further investigation.

Purpose of the Study:

  • To evaluate the TG/HDL-C ratio's predictive value for CKD in non-diabetic individuals.
  • To assess the association between the TG/HDL-C ratio and kidney function markers like estimated glomerular filtration rate (eGFR) and urinary albumin-to-creatinine ratio (UACR).

Main Methods:

  • 183 non-diabetic participants were classified based on eGFR and UACR using Kidney Disease Improving Global Outcomes criteria.
  • Estimated pulse wave velocity (ePWV) was calculated, and the TG/HDL-C ratio was determined.
  • Statistical analyses, including chi-squared tests and adjusted models, were employed to identify predictors.

Main Results:

  • The TG/HDL-C ratio showed an inverse association with eGFR and a positive association with UACR and ePWV.
  • A high TG/HDL-C ratio was significantly associated with lower eGFR, higher UACR, and hypertension.
  • The TG/HDL-C ratio independently predicted low eGFR and elevated UACR in older hypertensive individuals.

Conclusions:

  • The TG/HDL-C ratio serves as a potential predictor for reduced eGFR and albuminuria in non-diabetic patients.
  • Arterial stiffening is implicated as a key pathophysiological mechanism linking the TG/HDL-C ratio to CKD progression.
Abstract

Related Concept Videos

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
97
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance...
100
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
435
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
246
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
478
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
316